Edible foodstuffs and bio reactor design
AssigneeThe Fynder Group, Inc.
InventorsMark A. Kozubal, Richard E. Macur, Yuval C. Avniel, Maximilian Devane Hamilton
Life of this patent
Estimating the term…
Abstract
Methods of production of edible filamentous fungal biomat formulations are provided as standalone protein sources and/or protein ingredients in foodstuffs as well as a one-time use or repeated use self-contained biofilm-biomat reactor comprising a container with at least one compartment and placed within the compartment(s), a feedstock, a fungal inoculum, a gas-permeable membrane, and optionally a liquid nutrient medium.
Claims30
A food product, comprising:
- a piece of a filamentous fungal biomat, wherein the biomat consists essentially of mycelia and has been subjected to a treatment to eliminate cell viability;
- at least one additive selected from the group consisting of flavors, spices, flavor enhancers, fats, fat replacers, preservatives, sweeteners, color additives, nutrients, emulsifiers, stabilizers, thickeners, pH control agents, acidulants, leavening agents, anti-caking agents, humectants, yeast nutrients, dough strengtheners, dough conditioners, firming agents, enzyme preparations, gases, and combinations thereof;
- and
- wherein the piece is of a size consistent with the food product.
A food material, comprising filamentous fungal particles having an average particle size of about 75 to about 120 microns and a moisture content of less than about 14%, wherein the food material is a flour, wherein the filamentous fungal particles consist essentially of mycelia, and wherein the filamentous fungal particles have been subjected to a treatment to eliminate cell viability.
A food material, comprising filamentous fungal particles having an average particle length of about 0.4 mm to about 500 mm, an average particle width of about 0.4 mm to about 7 mm, and an average particle height of about 0.03 mm to about 1.0 mm, wherein the filamentous fungal particles consist essentially of mycelia and have been subjected to a treatment to eliminate cell viability.
Dependencies are inferred from the claim text.